• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
Nairametrics
No Result
View All Result
Home Economy Socio Economic

Moderna Covid-19 vaccine gets US approval

Chike Olisah by Chike Olisah
December 20, 2020
in Socio Economic, Spotlight
Covid-19: AstraZeneca vaccine gets huge boost, produces immune response in elderly, Vaccine, COVID-19: Russia to roll out vaccine in September ahead of the West 

Covid-19: AstraZeneca vaccine

Share on FacebookShare on TwitterShare on Linkedin

Moderna Inc’s coronavirus vaccine was cleared by US regulators on Friday, as it became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) this month.

This is a piece of good news to a nation with a staggering COVID-19 death toll of over 307,000 lives lost.

The decision of the FDA to grant authorization for the use of the vaccine means that 2 of the 6 vaccine candidates identified by Operation Warp Speed are now available to the general public.

RelatedStories

Covid-19: AstraZeneca vaccine gets huge boost, produces immune response in elderly, Vaccine, COVID-19: Russia to roll out vaccine in September ahead of the West 

AstraZenaca to launch new COVID-19 prevention drug amid global withdrawal of vaccine 

May 17, 2024
Moderna

Moderna Shares fall by 6.5% after reported loss in sales, production of Covid 19 vaccine

November 3, 2023

This authorization is coming a day after FDA’s panel of outside experts voted 20-0, with one absention, to endorse its use, and a week after the FDA authorized a vaccine from Pfizer Inc and German partner BioNTech SE.

The vaccine from Pfizer and BioNTech, based on similar technology, has been put into the arms of thousands of U.S. healthcare workers this week in a massive nationwide rollout. Moderna injections are expected to begin in coming days for adults 18 years old and up.

FDA Commissioner, Stephen Hahn, in a statement, said, “With the availability of two vaccines now for the prevention of COVID-19, the FDA has taken another crucial step in the fight against this global pandemic that is causing vast numbers of hospitalizations and deaths in the United States each day.’’

The speed of vaccine development is a stunning scientific success, although there is some hesitancy among the public.

Top U.S. infectious disease scientist, Anthony Fauci, in a statement, said, “It is my hope that all Americans will protect themselves by getting vaccinated when the vaccine becomes available to them. That is how our country will begin to heal and move forward.’’

Moderna said it intended to apply for full US approval in 2021, as the vaccine is also the first product from the company to get regulatory clearance for use.

Moderna’s vaccine, just like the one developed by Pfizer and BioNTech, is based on messenger RNA technology that had not been previously used before. The vaccine was shown to be nearly 95% effective with no serious safety concerns.

The vaccine, developed in partnership with the National Institutes of Health, had relatively minor side effects including pain around the injection site and swelling.

The biotech company is working with the US government for the distribution of 5.9 million shots as early as this weekend.

Moderna’s shot is expected to be used in harder-to-reach locations, such as rural hospitals. The vaccine needs to be stored and shipped frozen, but does not require the ultra-cold temperatures of the Pfizer/BioNTech shot.

U.S. President Donald Trump on Twitter expressed delight at the authorization as he said, “Congratulations, the Moderna vaccine is now available! The vaccine must be transported to hospitals and other centres before injections begin.”

Moderna said it would deliver approximately 20 million doses to the U.S. government this year and expected to have between 100 million and 125 million globally in the first quarter of next year, with 85-100 million of those for the United States.

What you should know

It can be recalled that Moderna Inc, over a month ago, certified its Covid-19 vaccine to be almost 95% effective in treating coronavirus and was able to prevent the most severe infections. The Trump administration, through its Operation Warp Speed, made available over $950 million to Moderna to develop the vaccine.

The US government has deals with Moderna to spend billions of dollars to provide a total of 200 million doses by the end of June 2021. This should be enough to immunize 100 million people, and there is an option to procure another 300 million doses.

Other vaccines that are still being tested, include a one-shot injection from Johnson & Johnson, and a two-shot course from AstraZeneca and Oxford University.


Follow us for Breaking News and Market Intelligence.
Tags: Covid-19 vaccineModerna Inc
Chike Olisah

Chike Olisah

Chike was a banker with over 11 years experience in retail and commercial banking, risk management, treasury portfolio management and relationship management. He also acquired some experience in financial management and do have some special interest in investment analysis and personal finance. He had stints with financial institutions like the former Intercontinental Bank and Fidelity Bank.

Related Posts

Covid-19: AstraZeneca vaccine gets huge boost, produces immune response in elderly, Vaccine, COVID-19: Russia to roll out vaccine in September ahead of the West 
Health

AstraZenaca to launch new COVID-19 prevention drug amid global withdrawal of vaccine 

May 17, 2024
Moderna
Health

Moderna Shares fall by 6.5% after reported loss in sales, production of Covid 19 vaccine

November 3, 2023
FEC approves process for indigenisation of vaccine production
Socio Economic

FEC approves process for indigenisation of vaccine production in Nigeria

September 15, 2022
CBN, THE SILVER LININGS OF COVID-19
Socio Economic

China approves world’s first inhalable Covid-19 vaccine in history

September 5, 2022
Canada to ease travel requirements as COVID-19 infection rates decline
Socio Economic

Canada to ease travel requirements as COVID-19 infection rates decline

February 16, 2022
Joe Biden gains additional 4.6 million Twitter followers in less than 12 hours
Socio Economic

US Supreme Court blocks Biden’s vaccine mandate for large businesses

January 14, 2022
Next Post
FG urges contractors to complete Ebute Meta–Apapa seaports railway extension by January 2021

FG urges contractors to complete Ebute Meta–Apapa seaports railway extension by January 2021

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

otd
access bank
nairametrics
Emple
Palmpay
first bank








DUNS

Recent News

  • Sujimoto founder Ogundele denies EFCC fraud allegations, cites delays in Enugu projects 
  • Weekly FX Wrap: Naira Strengthens across official and parallel markets in first week of September
  • NDLEA arrests 280 drug suspects in Oyo State, secures 43 convictions in 8 months 

Follow us on social media:

Recent News

EFCC declares Sujimoto boss, Olasijibomi Ogundele wanted for alleged fraud 

Sujimoto founder Ogundele denies EFCC fraud allegations, cites delays in Enugu projects 

September 5, 2025
Naira sinks in black market, U.S dollar posts best month in 2025

Weekly FX Wrap: Naira Strengthens across official and parallel markets in first week of September

September 5, 2025
  • iOS App
  • Android App
  • Contact Us
  • Home
  • Markets
  • Sectors
  • Economy
  • Business News
  • Financial Literacy
  • Disclaimer
  • Ads Disclaimer
  • Copyright Infringement

© 2025 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Login
  • Sign Up

© 2025 Nairametrics